Troponin in COVID-19: To Measure or Not to Measure? Insights from a Prospective Cohort Study

Troponin in COVID-19: To Measure or Not to Measure? Insights from a Prospective Cohort Study

Myocardial injury (MI), defined by troponin elevation, has been associated with increased mortality and adverse outcomes in patients with coronavirus disease 2019 (COVID-19), but the role of this biomarker as a risk predictor remains unclear. Data from adult patients hospitalized with COVID-19 were...

Full description

Bibliographic Details
Main Authors: Renata Moll-Bernardes, João D. Mattos, Eduardo B. Schaustz, Andréa S. Sousa, Juliana R. Ferreira, Mariana B. Tortelly, Adriana M. L. Pimentel, Ana Cristina B. S. Figueiredo, Marcia M. Noya-Rabelo, Allan R. K. Sales, Denilson C. Albuquerque, Paulo H. Rosado-de-Castro, Gabriel C. Camargo, Olga F. Souza, Fernando A. Bozza, Emiliano Medei, Ronir R. Luiz
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Journal of Clinical Medicine
Subjects:
troponin
myocardial injury
biomarker
COVID-19
prognosis
Online Access:https://www.mdpi.com/2077-0383/11/19/5951

Internet

https://www.mdpi.com/2077-0383/11/19/5951

Similar Items